Grabowski, F., Preibisch, G., Giziński, S., Kochańczyk, M., & Lipniacki, T. (2021). SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations. Viruses.
Chicago Style CitationGrabowski, Frederic, Grzegorz Preibisch, Stanisław Giziński, Marek Kochańczyk, i Tomasz Lipniacki. "SARS-CoV-2 Variant of Concern 202012/01 Has About Twofold Replicative Advantage and Acquires Concerning Mutations." Viruses 2021.
Cita MLAGrabowski, Frederic, et al. "SARS-CoV-2 Variant of Concern 202012/01 Has About Twofold Replicative Advantage and Acquires Concerning Mutations." Viruses 2021.
Atenció: Aquestes cites poden no estar 100% correctes.